Julien Douet

Scientific Director, Global Drug Substance Development

Vevey, Vaud, Switzerland

About

Experience

  • Merck Group (8 yrs 4 mos)
    • Scientific Director, Global Drug Substance Development
      Jan 2025 - Present · 1 yr 6 mos

    • Co-Lead Technology Innovation group (ad-interim)
      Feb 2024 - Jan 2025 · 1 yr

      Leading CLD, USP, Robotic-Automation innovation activities

    • Head Cell Line Technologies
      Apr 2021 - Jan 2024 · 2 yrs 10 mos

      Scientific Innovation lead in the field of Cell Line Development Scientific monitoring, Business Development and IP Coordination of innovation projects PhD supervision Communication and representation

  • Visiting Lecturer - Polytech Clermont at Polytech Clermont
    2022 - 2023 · 1 yr

  • Visiting Lecturer FHNW at University of Applied Sciences and Arts Northwestern Switzerland FHNW
    2021 - 2021 · Less than a year

  • Postdoctoral Researcher at Fundación Josep Carreras contra la Leucemia
    Jun 2015 - Jul 2017 · 2 yrs 2 mos

    Epigenetic regulation and chromatin structure. Techniques: ChIP-Seq; UMI-4C; Enhancer Blocking Assay; Gibson assembly; Immunoprecipitation; shRNA ; siRNA ; CRISPR/Cas9. Photonic and confocal microscopy (3D-FISH; Immunocytology; Proximity Ligation Assay...). Cell-based assays (colony formation assay; wound healing; Lenti- and Retroviral particule production...). Awarded a grant from the Spanish Ministry of Economy, Industry and Competitiveness.

  • Visiting Lecturer at L'École Normale Supérieure de Lyon
    Oct 2016 - Oct 2016 · 1 mo

    Lecture on the technological breakthroughs that permited the recent advances in chromatin structure field (for Master students).